No more cheap weight loss meds [FeC7UxOfqjp]

The FDA has declared the tirzepatide shortage officially over, giving Lilly exclusive rights to distribute their product for at least the next 60–90 days. This transition means compounded versions, previously available at lower costs, are no longer permissible. Companies and compounding pharmacies that relied on these products are now facing significant challenges, with lawsuits and pushback expected as the industry adjusts. Meanwhile, medications like Ozempic are still available, but this development underscores the broader risks of depending on compounded alternatives during shortages. The situation could lead to regulatory disputes and further complications as pharmacies and companies adapt to these changes. #FDAupdate #weightlossdrugs #compoundedmedications #pharmacychallenges #medicationshortage #drugwars #healthcareregulations #pharmaindustry #ozempic #trizepatide #darshantalks #dt #kulkarnilawfirm #klf #recentrecap Website: Law Firm: Twitter: LinkedIn: Sign up for my newsletter: ---- Disclaimers: This discussion is provided for general educational purposes and should not be construed as legal advice, regulatory advice or medical advice. Listening to this video or otherwise depending on discussions in this video do not, in any way, create an attorney attorney-client relationship #medical weight loss cincinnati #keto blast gummi bears #bio fuel keto and acv gummies #best gummy diet pills